Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results

NEXT STORY
Teladoc Health Sees Daily Virtual Medical Visits Up 50% in Past Week
PREV STORY
Humidity helps in the fight against COVID-19, virologists report
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aduro Biotech Announces Promising Preclinical Data that Validate Anti-CTLA-4 Antibody ADU-1604

BERKELEY, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

New England Journal of Medicine Publishes Results of Phase 3 POISE Trial of Ocaliva® (Obeticholic Acid) for the Treatment of PBC

NEW YORK, Aug. 17, 2016 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical ...

author_avatar
NASDAQ Market News

Immunocore strengthens IP position in the field of TCR-based therapeutics

PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of ...

author_avatar
NASDAQ Market News